Summary
The Folate congeners act as one carbon donor or accep tor in intracellular biochemical reactions, including biosynthesis of nucleic acid and metabolism of amino acid. Since the homeostasis of these reactions is essen tial for normal cell replication, an adequate and con stant supply of folate is necessary (1) . For this purpose, PteGlu is supplemented to many domestic animals. Especially in pigs, it is generally perceived the supple mentation with PteGlu is important for pregnant sows because plasma folate levels decrease during pregnancy (2, 3) .
It is well known that PteGlu is inactive as a cofactor unless it is converted to a reduced form. In the begin ning of conversion steps in the body, PteGlu is reduced to H4PteGlu by DHFR. H4PteGlu is converted to other forms of reduced folates, including 5-CH3-H4PteGlu. However Kokue et al. demonstrated that the plasma concentrations of H4PteGlu and 5-CH3-H4PteGlu do * To whom correspondence should be addressed .
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One possible explanation may be a difference in DHFR activity for PteGlu between pigs and rats. In this study, therefore, we evaluated DHFR activity for PteGlu in pigs and rats and compared the results between the species. The administered PteGlu is mainly taken up by the liver, metabolized to reduced forms of folate, and then secreted into bile (1) . Since the bile secretion rate of reduced folates may reflect the DHFR activity for PteGlu in the body, the secretion rate after PteGlu injec tion was examined as the indicator of the activity in vivo. After intravenous injection of PteGlu to pigs and rats, the bile secretion rates of reduced folates, including H4PteGlu, 5-CH3-H4PteGlu, 5, 10-CH2-H4PteGlu, and 10-HCO-H4PteGlu, were determined by HPLC-ECD. Plasma kinetics of the reduced folates and the injected PteGlu were also examined by different series of experi ments in both animal species, because the bile drainage decreases plasma concentration of reduced folates (6, 7) . In addition to the in vivo experiments, we examined DHFR activity for PteGlu using partially purified DHFR 
RESULTS
In vivo experiments Bile secretion rate of reduced folates. Figure 1 shows the bile secretion rate of H4PteGlu, 5-CH3-H4PteGlu, 5, 10-CH2-H4PteGlu, 10-HCO-H4PteGlu, and the sum of these reduced folates in pigs and rats, after the intra venous injection of PteGlu or H2PteGlu. The amounts of reduced folate in bile, which increased from their base line were calculated by the trapezoidal rule from 0h to 2.5h after the injection, and these amounts and the composition of each reduced folate were summarized in Table 1 . Although the bile secretion rate of reduced fo lates increased in both species after the PteGlu injec tion, the extent of the increase in pigs was much less than that in rats. As shown in Table 1 , the total in creased amount of reduced folates in pigs was no more than 1/10 of that in rats after PteGlu injection. In pig bile, the total increase of reduced folates after PteGlu injection was lower than that after H2PteGlu in jection. However, those amounts in rats were compara ble after the injections of PteGlu and H2PteGlu. Furthermore, the ratio of the amount in pigs to that in rats was about 1/3 after H2PteGlu injection, indicating that the rate of the reduction from PteGlu to H2PteGlu in pigs was much slower than that in rats.
As shown in Table 1 , it was observed that the 5,10 -CH2-H4PteGlu increased most prominently after the PteGlu or H2PteGlu injection to pigs, and after the PteGlu injection to rats, whereas the 5-CH3-H4PteGlu increased most prominently only after H2PteGlu injec tion to rats.
Plasma concentrations of folates. Figure 2 exhibits the plasma concentration of reduced folates after the in jections of PteGlu and H2PteGlu to pigs and rats. As shown in Fig. 2 , the total plasma concentrations of re duced folates increased after the PteGlu injection to pigs and rats, and the increase in pigs was less than that in rats. However, the notable difference was observed in the bile secretion rate between the species. After the PteGlu injection, no increase was observed in the plasma concentrations.
By comparing the maximal value of the total concentrations of plasma reduced fo lates after PteGlu and H2PteGlu injection to pigs, we see that the concentration after PteGlu injection was about 1/2 of that after H2PteGlu injection.
After the injections of both compounds, the plasma concentration-time profile on PteGlu and H2PteGlu in pigs and rats were determined and the pharmacokinetic parameters were shown in Table 2 . While the kel for PteGlu in pigs was smaller than that for H2PteGlu in pigs and that for PteGlu in rats, AUC of both compounds in both animals were almost the same, suggesting that the injected PteGlu or H2PteGlu was equally exposed to the liver in pigs and rats. the exposures of PteGlu to the livers were almost same after the injection to both animals. The great difference observed in the bile profile after PteGlu injection be tween pigs and rats was not observed in the plasma pro file (Fig. 2) . These findings from in vivo and in vitro experiments demonstrate that the DHFR activity for PteGlu in pigs was much less than that in rats. The low DHFR activity in pigs may be one of the causal factors of the fact that the plasma H4PteGlu and 5-CH3-H4PteGlu did not in crease after oral administration of PteGlu, even at high dose (4, 13) . The reduction of PteGlu to H2PteGlu in pigs may be regarded as the rate-limiting step for the re duction of PteGlu to H4PteGlu, because the Vmax of pig liver DHFR for PteGlu was remarkably small, compared with that for H2PteGlu ( Table 3 ). The increase in the se cretion rate of reduced folates in bile was much less after PteGlu injection to pigs than that after H2PteGlu injection (Fig. 1) . As summarized in Fig.  1 and Table  1 , among the re duced folates, the 5, 10-CH2-H4PteGlu increased most prominently after PteGlu or H2PteGlu injection to pigs, and after PteGlu injection to rats. However, the 5 -CH3-H4PteGlu increased most prominently after H2PteGlu injection to rats. Suppose that PteGlu and H2PteGlu are both initially reduced to H4PteGlu by DHFR, and then H4PteGlu receives one carbon unit and acts as a one-carbon donor (15) , the component of each reduced folate secreted into bile should be demonstrated similarly after PteGlu and H2PteGlu injections. Our ob servations contradicted the fact that PteGlu as well as H2PteGlu is reduced to H4PteGlu by DHFR. Therefore, our results suggest that there exists another metabolic pathway of H2PteGlu to another form of reduced folates other than H4PteGlu in rats. This unknown metabolic pathway may not relate to the metabolism of PteGlu in rats, because the reduction to H4PteGlu may proceed immediately after the reduction to H2PteGlu by DHFR, considering that the Km of DHFR for H2PteGlu was ex tremely lower, and that the Vax of DHFR for H2PteGlu was much faster compared with that for PteGlu (Table  3) . It may be thought that the difference in secretion profiles after PteGlu and H2PteGlu injection to rats might be due to the difference in the metabolic pathway of PteGlu and H2PteGlu to form reduced folates in rats.
